Is NiceRx a Praxbind coupon provider?
We are a service provider that helps eligible individuals access the Praxbind patient assistance program. That means that we do not offer printable Praxbind manufacturer coupons, Praxbind discounts, or free Praxbind samples. We are not a Praxbind coupon provider or Praxbind discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.
Praxbind patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Praxbind cheaper if I have insurance?
How much does Praxbind cost without insurance?
Praxbind cost without insurance will vary depending on where you buy it. As a guide, Praxbind intravenous solution (2.5 g/50 mL) usually costs $4,700 for 100 milliliters. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.
How much does Praxbind cost with insurance?
The copay for Praxbind with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.
What is Praxbind?
Praxbind is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. Praxbind is a humanized monoclonal antibody fragment used in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran etexilate is needed to prevent blood clots, for emergency surgery/urgent procedures, in life-threatening or uncontrolled bleeding. Idarucizumab is a specific reversal agent for dabigatran. It does not affect other anticoagulants or antithrombotic therapies.
This use is approved under accelerated approval based on a reduction in unbound dabigatran and normalization of coagulation parameters in healthy volunteers. Continued approval for this use may depend on the results of an ongoing (RE-VERSE AD) cohort case series study, consisting of patients taking Pradaxa to prevent stroke due to atrial fibrillation.
Patients treated with dabigatran have underlying disease conditions that make them more prone to thromboembolic events. Resuming anticoagulant therapy should be considered as soon as appropriate to reduce this risk.
What doses of Praxbind are available?
Praxbind is available in injection form, in the following doses: 2.5 g/50 mL solution in a single-use vial.
Intravenous administration of idarucizumab 5 g (2 vials, each containing 2.5 g) as two consecutive infusions or a bolus injection by injecting both vials one after the other. There is limited data to support the administration of an additional dose of idarucizumab. Relevant coagulation parameters are, activated partial thromboplastin time (aPTT), diluted thrombin time (DTT), or ecarin clotting time (ECT).
Please see the full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Praxbind active ingredients
Praxbind contains idarucizumab as the active ingredient.
Praxbind side effects
The most common side effects of Praxbind in clinical trials compared to placebo include:
In rare instances, Praxbind can cause more serious side effects. These can include:
- Thromboembolic risk
- Re-elevation of coagulation parameters – an additional 5 g dose of Praxbind may be considered
- Hypersensitivity reactions
- Risks of serious adverse reactions in patients with hereditary fructose intolerance due to sorbitol excipient
Your doctor will assess the benefits of using Praxbind against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Praxbind to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Praxbind drug interactions
Other drugs may interact with Praxbind, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.
You should not use Praxbind if you:
- Are allergic to the active ingredient idarucizumab
- Are allergic to any of the other ingredients in Praxbind
Talk to your doctor before using Praxbind if you:
- Are taking any of the medications that could interact with Praxbind
- Have renal impairment, or hepatic impairment
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Praxbind is the trademark brand name for idarucizumab manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. A generic version of idarucizumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Praxbind savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.